Americas

Businesses increasingly realize that significant growth opportunities are unlikely to come from incremental change.

Learning what, when and where it's needed.

It's not easy to alter engrained behavior even when that behavior is clearly
counterproductive — but, fortunately for the health of our organizations, it is possible.

Everywhere you go business people are asking the same questions about
Internet commerce. Why are profits scarce or nonexistent? Why is there so
much uncertainty about Internet business models? When will some modicum
of order emerge from the chaos of doing business on the Web?

The Office of the Governor of the State of California and representatives from Life Sciences clusters produced strategic action plans.

Scenario Thinking for Business Executives and Corporate Boards.

Today's executives need to integrate their "risk management" and "risk-taking" sides.

In these uncertain, complex, and volatile times, risk seems to be shifting and accelerating.

The antithesis of a traditional business model, biotechnology company Maxygen is the poster child for a new “biomolecular” way of organizing enterprise. Monitor’s Chris Meyer and Joan Chu analyze Maxygen’s paradigm – and question its sustainability – in their The Journal of Life Sciences article.

With human infection from the avian influenza virus confirmed in ten countries, the avian flu is a serious threat.

Today’s emphasis on innovation in the biopharmaceutical industry is driven by the resistance of payers to pay premium prices for medicines.

The real work of raising productivity and innovative capacity occurs in the cities and regions where firms are based.

Almost everybody loves to think about the future, especially people in organizations.

The South Carolina Competitiveness Initiative is a two-year project that began with an assessment of the competitiveness.

A six month strategy development effort involving dozens of private and public sector organizations in the Berkshires.